135 related articles for article (PubMed ID: 35042146)
1. Population-based cancer survival in the Golestan province in the northeastern part of Iran 2007-2012.
Nemati S; Saeedi E; Roshandel G; Nahvijou A; Badakhshan A; Akbari M; Sedaghat SM; Hasanpour-Heidari S; Hosseinpour R; Salamat F; Lotfi F; Khosravi A; Soerjomataram I; Bray F; Zendehdel K
Cancer Epidemiol; 2022 Apr; 77():102089. PubMed ID: 35042146
[TBL] [Abstract][Full Text] [Related]
2. Cancer incidence in Golestan Province: report of an ongoing population-based cancer registry in Iran between 2004 and 2008.
Roshandel G; Sadjadi A; Aarabi M; Keshtkar A; Sedaghat SM; Nouraie SM; Semnani S; Malekzadeh R
Arch Iran Med; 2012 Apr; 15(4):196-200. PubMed ID: 22424034
[TBL] [Abstract][Full Text] [Related]
3. Analysis of Competing Risks of Causes of Death in Cancer Patients from Golestan, Iran over Twelve Years (2004-2016).
Zare M; Hasanpour-Heidari S; Semnani S; Fazel A; Sedaghat SM; Semnani Y; Mansuri SM; Gholami M; Araghi M; Roshandel G
Asian Pac J Cancer Prev; 2021 Oct; 22(10):3137-3142. PubMed ID: 34710989
[TBL] [Abstract][Full Text] [Related]
4. Temporal and Geographical Trends of Incidence of Thyroid Cancer in Golestan, Iran, 2004-2013.
Salamat F; Aryannia A; Rajaei S; Naeimi-Tabiei M; Afghani R; Sedaghat SM; Naeimi-Tabiei E; Salamat F; Hosseinpour R; Fazel A; Araghi M; Roshandel G
Arch Iran Med; 2021 Jan; 24(1):1-6. PubMed ID: 33588561
[TBL] [Abstract][Full Text] [Related]
5. Primary Liver Cancer in Golestan Province, Northeastern Iran: 13-Year Experience of Golestan Population-Based Cancer Registry (GPCR).
Isapanah Amlashi F; Ashkbari A; Amiriani T; Norouzi A; Poorkhani AH; Sedaghat SM; Livani S; Ashaari M; Sadeghzadeh H; Besharat S; Semnani S; Roshandel G
Arch Iran Med; 2021 Oct; 24(10):727-732. PubMed ID: 34816693
[TBL] [Abstract][Full Text] [Related]
6. Marked increase in breast cancer incidence in young women: A 10-year study from Northern Iran, 2004-2013.
Fazel A; Hasanpour-Heidari S; Salamat F; Rajaie S; Kazeminezhad V; Naeimi-Tabiei M; Jahangirrad A; Sedaghat S; Hosseinpoor R; Ghasemi-Kebria F; Roshandel G; Weiderpass E
Cancer Epidemiol; 2019 Oct; 62():101573. PubMed ID: 31330422
[TBL] [Abstract][Full Text] [Related]
7. Primary Biliary Tract Cancers in Golestan, Iran: 13-Year Experience of Golestan Population-Based Cancer Registry.
Ashkbari A; Isapanah Amlashi F; Besharat S; Mofidi M; Amiriani T; Fazel A; Alimadadi M; Salamat F; Sedaghat SM; Livani S; Bagheri A; Semnani S; Norouzi A; Roshandel G
Arch Iran Med; 2023 Sep; 26(9):504-509. PubMed ID: 38310406
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of Head and Neck Cancers in Northern Iran: A 10-Year Trend Study From Golestan Province.
Taziki MH; Fazel A; Salamat F; Sedaghat SM; Ashaari M; Poustchi H; Shakeri R; Hoseinpoor R; Hasanpour-Heidari S; Roshandel G
Arch Iran Med; 2018 Sep; 21(9):406-411. PubMed ID: 30221531
[TBL] [Abstract][Full Text] [Related]
9. Male skin cancer incidence in Golestan province, Iran.
Marjani A; Kabir MJ
J Pak Med Assoc; 2009 May; 59(5):287-9. PubMed ID: 19438130
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of leukemia and multiple myeloma in Golestan, Iran.
Rajabli N; Naeimi-Tabeie M; Jahangirrad A; Sedaghat SM; Semnani S; Roshandel G
Asian Pac J Cancer Prev; 2013; 14(4):2333-6. PubMed ID: 23725136
[TBL] [Abstract][Full Text] [Related]
11. Temporal and geographical variations in colorectal cancer incidence in Northern Iran 2004-2013.
Hasanpour-Heidari S; Fazel A; Semnani S; Khandoozi SR; Amiriani T; Sedaghat S; Hosseinpoor R; Azarhoush R; Poorabbasi M; Naeimi-Tabiei M; Roshandel G; Bray F; Weiderpass E
Cancer Epidemiol; 2019 Apr; 59():143-147. PubMed ID: 30771699
[TBL] [Abstract][Full Text] [Related]
12. National surveillance of cancer survival in Iran (IRANCANSURV): Analysis of data of 15 cancer sites from nine population-based cancer registries.
Nemati S; Saeedi E; Lotfi F; Nahvijou A; Mohebbi E; Ravankhah Z; Rezaeianzadeh A; Yaghoobi-Ashrafi M; Pirnejad H; Golpazir A; Dolatkhah R; Alvand S; Ahmadi-Tabatabaei SV; Cheraghi M; Weiderpass E; Bray F; Coleman MP; Etemadi A; Khosravi A; Najafi F; Mohagheghi MA; Roshandel G; Malekzadeh R; Zendehdel K
Int J Cancer; 2022 Dec; 151(12):2128-2135. PubMed ID: 35869869
[TBL] [Abstract][Full Text] [Related]
13. Descriptive Epidemiology of Lymphoma in Northern Iran: Results from the Golestan Registry 2004-2013.
Jafari-Delouei N; Naeimi-Tabiei M; Fazel A; Ashaari M; Hatami E; Sedaghat SM; Poorabbasi M; Hasanpour-Heidari S; Ghasemi-Kebria F; Salamat F; Moghaddami A; Gholami M; Bray F; Roshandel G
Arch Iran Med; 2020 Mar; 23(3):150-154. PubMed ID: 32126782
[TBL] [Abstract][Full Text] [Related]
14. Incidence, Time Trends and Geographical Distribution of Leukemia and Multiple Myeloma in Golestan Province, Northern Iran, 2004-2017.
Jafari-Delouei N; Naimi-Tabiei M; Farajollahi M; Sedaghat SM; Khandoozi S; Ghasemi-Kebria F; Dinparastisaleh R; Pourkhani A; Roshandel G
Arch Iran Med; 2022 Jun; 25(6):360-365. PubMed ID: 35943015
[TBL] [Abstract][Full Text] [Related]
15. Trends in the Incidence of Stomach Cancer in Golestan Province, a High-risk Area in Northern Iran, 2004-2016.
Ghasemi-Kebria F; Amiriani T; Fazel A; Naimi-Tabiei M; Norouzi A; Khoshnia M; Seyyedmajidi M; Pooshani A; Mousaviemadi S; Poorkhani H; Sedaghat S; Salamat F; Hasanpour-Heidari S; Jafari-Delouie N; Gholami M; Semnani S; Roshandel G; Weiderpass E; Malekzadeh R
Arch Iran Med; 2020 Jun; 23(6):362-368. PubMed ID: 32536172
[TBL] [Abstract][Full Text] [Related]
16. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
17. Recent cancer incidence trends and short-term predictions in Golestan, Iran 2004-2025.
Roshandel G; Ferlay J; Semnani S; Fazel A; Naeimi-Tabiei M; Ashaari M; Amiriani T; Honarvar M; Sedaghat S; Hasanpour-Heidari S; Salamat F; Mansoury M; Ghasemi-Kebria F; Mirkarimi H; Jafari-Delouei N; Shokoohifar N; Vignat J; Weiderpass E; Malekzadeh R; Bray F
Cancer Epidemiol; 2020 Aug; 67():101728. PubMed ID: 32554298
[TBL] [Abstract][Full Text] [Related]
18. Incidence and Temporal Variations of Bone and Soft Tissue Cancers in the Golestan Province, Northern Iran, 2004-2016.
Soghi A; Aarabi M; Sedaghat SM; Salamat F; Ghasemi-Kebria F; Roshandel G; Abdolahi N
Arch Iran Med; 2023 Feb; 26(2):62-68. PubMed ID: 37543925
[TBL] [Abstract][Full Text] [Related]
19. Increasing trends of lung cancer in Golestan province, Northern Iran (2004-2016).
Salamat F; Khandashpour M; Naeimi-Tabiei M; Ariannia A; Ashaari M; Sedaghat S; Ghasemi-Kebria F; Salamat F; Moghaddami A; Hasanpour-Heidari S; Hoseinpour R; Jafari-Delouei N; Ghayoriardahaei H; Gholami M; Fazel A; Roshandel G; Ferlay J; Weiderpass E
Cancer Epidemiol; 2020 Apr; 65():101687. PubMed ID: 32087554
[TBL] [Abstract][Full Text] [Related]
20. Five-year relative survival and determinants of excess mortality in patients with head and neck and thyroid cancers: A population-based study from Golestan province, Northern Iran.
Taziki M; Rajaei S; Firouzei G; Hashemzadeh F; Rajabalian M; Mansoury M; Sedaghat S; Ghahraman F; Ghasemi-Kebria F; Weiderpass E; Roshandel G
Cancer Epidemiol; 2022 Oct; 80():102247. PubMed ID: 36081275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
